An expert discusses treatment strategies for immune thrombocytopenic purpura (ITP), emphasizing individualized decisions based on platelet count, bleeding symptoms, and comorbidities, with options ...
An expert discusses how rilzabrutinib’s oral administration and broad tolerability make it a practical treatment option while ...
From MIGS integration to remote monitoring and next-generation therapeutics, glaucoma specialists explore how new approaches ...
The researchers argue that the integration of explainable AI into clinical decision-making pipelines could reshape cancer ...
In a recent study posted to the medRxiv* preprint server, researchers developed a personalized therapy selection algorithm for two diabetes type 2 (T2D) treatment drug classes, i.e., sodium-glucose ...
Oncology-focused biotech company Guardant Health is partnering with AI drug development company Zephyr AI to combine AI and ...
Circulating Tumor DNA Genotyping of Intrinsic and Acquired Gene Alterations in Patients With Advanced Breast Cancer Receiving Palbociclib: Biomarker Results From POLARIS Study FOLFIRINOX (FFX) and ...
Resmed Inc (($RMD)) announced an update on their ongoing clinical study. Study Overview: ResMed Inc is conducting a study titled ‘Evaluation of a ...
The Pediatric Emergency Medicine and Pediatric Hematology/Oncology divisions at MUSC have joined forces to create and test an algorithm for treating children with sickle cell disease who present to ...
Reflecting the growing understanding of rosacea as a continuum of systemic inflammation, new National Rosacea Society (NRS) Treatment Algorithms suggest therapies based not on the rosacea subtype but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback